FAS and neoplasm: It was shown that patients with a higher FAS-expression have a longer recurrence free and overall survival, even when corrected for age, histological subtype, tumor grade, tumor stage, ER-status, year of diagnosis, neo-adjuvant treatment, adjuvant chemotherapy and adjuvant endocrine therapy.